On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini. This instrumentation change is necessary as Bio-Rad is discontinuing service on our existing QuickStep instrumentation.
Although the Immucor assay and sample requirements will remain the same, the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list will be available on the CTS website on 04/29/19.
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...